Skip to main content
Clinical Trials/NCT03146026
NCT03146026
Completed
Not Applicable

The Effects of a 12- Week Combined Exercise Training Program on Arterial Stiffness, Endothelial Function, Inflammatory Markers and Metabolic Profile in Obese Adolescent Girls: A Pilot Study.

Pusan National University0 sites30 target enrollmentFebruary 8, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity, Adolescent
Sponsor
Pusan National University
Enrollment
30
Primary Endpoint
Body fat
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study was to examine the impact of 12 weeks of combined exercise training (CET) on arterial stiffness, endothelial function, inflammatory markers, insulin resistance, and body composition in obese adolescent girls. Thirty obese adolescent girls participated in this study. The girls were randomly divided into CET group (n=15) and control group (n=15). The CET group performed concurrent resistance training followed by aerobic training at 40-70% of the heart rate reserves (HRR) 3 days/week for 12 weeks. Plasma nitric oxide, endothelin-1, C-reactive protein, arterial stiffness, homeostasis model assessment of insulin resistance (HOMA-IR), glucose, insulin, and the adiponectin/leptin ratio were measured before and after the 12-weeks study.

Registry
clinicaltrials.gov
Start Date
February 8, 2010
End Date
May 6, 2011
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Won-mok son

Principal Investigator

Pusan National University

Eligibility Criteria

Inclusion Criteria

  • Obese with hyperinsulinemia
  • Abdominal obesity
  • Sedentary (no regular exercise training or physical activity)
  • No weight loss diet during last 6 months.

Exclusion Criteria

  • Hypertension
  • Pregnancy
  • Chronic disease

Outcomes

Primary Outcomes

Body fat

Time Frame: 12 weeks

Percent body fat (%) was determined using a bioelectrical impedance-meter.

Insulin resistance

Time Frame: 12 weeks

Insulin resistance was estimated using the homeostasis model assessment of insulin resistance (HOMA-IR).

Plasma adiponectin

Time Frame: 12 weeks

Plasma adiponectin was measured using ELISA kit

Waist circumference

Time Frame: 12 weeks

Waist circumference was measured at midpoint between the lower rib and the iliac crest at the end of a normal expiration using a tape measure

Maximal heart rate

Time Frame: 12 weeks

Maximal heart rate was obtained at the end of a graded treadmill exercise test performed until volitional exhaustion.

Nitric oxide

Time Frame: 12 weeks

Nitric oxide generation was measured by Griess assay kit.

Endothelin-1

Time Frame: 12 weeks

Levels of Endothelin-1 in blood were measured by Endothelin-1 enzyme immunoassay kit.

Body weight

Time Frame: 12 weeks

Body weight was measured to nearest 0.1 kg.

Height

Time Frame: 12 weeks

Height was measured to nearest 1 cm.

Arterial stiffness

Time Frame: 12 weeks

Arterial stiffness was measured as measurement of baPWV (m/s).

Plasma leptin

Time Frame: 12 weeks

Plasma leptin was determined by ELISA kit

Similar Trials